Total Payments
$15,229
2024 Payments
$127.98
Companies
40
Transactions
146
Medicare Patients
3,049
Medicare Billing
$988,276
Payment Breakdown by Category
Research$12,514 (82.2%)
Food & Beverage$2,203 (14.5%)
Consulting$500.00 (3.3%)
Other$11.20 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $12,514 | 15 | 82.2% |
| Food and Beverage | $2,203 | 129 | 14.5% |
| Consulting Fee | $500.00 | 1 | 3.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $11.20 | 1 | 0.1% |
Payments by Type
Research
$12,514
15 transactions
General
$2,714
131 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eli Lilly and Company | $11,156 | 3 | $0 (2019) |
| Biogen, Inc. | $1,359 | 12 | $0 (2017) |
| US WorldMeds, LLC | $797.70 | 3 | $0 (2018) |
| ABBVIE INC. | $406.42 | 26 | $0 (2024) |
| Allergan, Inc. | $222.37 | 16 | $0 (2022) |
| GENZYME CORPORATION | $182.84 | 8 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $165.73 | 8 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $113.70 | 21 | $0 (2017) |
| EMD Serono, Inc. | $64.41 | 5 | $0 (2018) |
| Merz Pharmaceuticals, LLC | $55.87 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $127.98 | 6 | ABBVIE INC. ($55.09) |
| 2023 | $453.32 | 26 | AbbVie Inc. ($191.81) |
| 2022 | $122.89 | 6 | ABBVIE INC. ($52.00) |
| 2021 | $28.53 | 2 | AbbVie Inc. ($28.53) |
| 2020 | $44.76 | 3 | Allergan, Inc. ($44.76) |
| 2019 | $2,705 | 18 | Eli Lilly and Company ($2,431) |
| 2018 | $9,238 | 33 | Eli Lilly and Company ($8,725) |
| 2017 | $2,508 | 52 | Biogen, Inc. ($1,359) |
All Payment Transactions
146 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | ABBVIE INC. | VYALEV (Drug), DUOPA | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: NEUROSCIENCE | ||||||
| 11/01/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: Neuroscience | ||||||
| 10/17/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $33.33 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/01/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: Neurology | ||||||
| 07/30/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: Neurology | ||||||
| 02/14/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: Neurology | ||||||
| 12/11/2023 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: Neurology | ||||||
| 11/08/2023 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $55.87 | General |
| Category: Musculoskeletal | ||||||
| 10/30/2023 | Microtransponder, Inc. | — | Food and Beverage | Cash or cash equivalent | $21.87 | General |
| 10/23/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $22.51 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2023 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $31.31 | General |
| Category: NEUROLOGY | ||||||
| 10/18/2023 | Microtransponder, Inc. | — | Food and Beverage | Cash or cash equivalent | $13.11 | General |
| 09/26/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/30/2023 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: EPILEPSY | ||||||
| 08/28/2023 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: Neurology | ||||||
| 08/08/2023 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $18.63 | General |
| Category: Neurology | ||||||
| 07/28/2023 | Lilly USA, LLC | AMYVID (Drug) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: Neuroscience | ||||||
| 07/20/2023 | AbbVie Inc. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $5.35 | General |
| Category: NEUROSCIENCE | ||||||
| 07/19/2023 | GE HealthCare | — | Food and Beverage | Cash or cash equivalent | $11.13 | General |
| 07/11/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 06/07/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 05/30/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 05/08/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $9.06 | General |
| Category: NEUROSCIENCE | ||||||
| 05/01/2023 | GE HealthCare | — | Food and Beverage | Cash or cash equivalent | $13.98 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| ASSESSMENT OF SAFETY, TOLERABILITY, AND EFFICACY OF LY3303560 IN EARLY SYMPTOMATIC ALZHEIMER'S DISEASE | Eli Lilly and Company | $10,137 | 2 |
| Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of BIIB054 in Participants With Parkinson's Disease | Biogen, Inc. | $1,359 | 12 |
| ASSESSMENT OF SAFETY, TOLERABILITY AND EFFICACY OF LY3002813 ALONE AND IN COMBINATION WITH LY3202626 IN EARLY SYMPTOMATIC ALZHEIMERS DISEASE | Eli Lilly and Company | $1,019 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 718 | 26,637 | $1.0M | $370,634 |
| 2022 | 12 | 792 | 14,339 | $537,063 | $148,181 |
| 2021 | 11 | 676 | 12,929 | $481,895 | $138,863 |
| 2020 | 19 | 863 | 23,837 | $993,117 | $330,599 |
Total Patients
3,049
Total Services
77,742
Medicare Billing
$988,276
Procedure Codes
61
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 3 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2020 | 34 | 44 | $22,440 | $4,077 | 18.2% |
| 70551 | Mri scan brain | Office | 2020 | 38 | 38 | $75,240 | $3,672 | 4.9% |
| 70553 | Mri scan of brain before and after contrast | Office | 2020 | 14 | 14 | $31,290 | $2,680 | 8.6% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | Office | 2020 | 30 | 46 | $10,488 | $2,502 | 23.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 39 | 42 | $6,300 | $2,300 | 36.5% |
| 72141 | Mri scan of upper spinal canal | Office | 2020 | 18 | 18 | $27,324 | $1,407 | 5.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 13 | 18 | $2,880 | $1,045 | 36.3% |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | Office | 2020 | 21 | 142 | $2,130 | $725.57 | 34.1% |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis | Office | 2020 | 19 | 40 | $6,640 | $673.94 | 10.1% |
| A9585 | Injection, gadobutrol, 0.1 ml | Office | 2020 | 22 | 2,400 | $3,600 | $672.12 | 18.7% |
| 96375 | Injection of different drug or substance into a vein for therapy, diagnosis, or prevention | Office | 2020 | 12 | 48 | $4,800 | $594.87 | 12.4% |
About Dr. Bradley Robottom, MD
Dr. Bradley Robottom, MD is a Neurology healthcare provider based in Durham, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/20/2007. The National Provider Identifier (NPI) number assigned to this provider is 1558486688.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bradley Robottom, MD has received a total of $15,229 in payments from pharmaceutical and medical device companies, with $127.98 received in 2024. These payments were reported across 146 transactions from 40 companies. The most common payment nature is "" ($12,514).
As a Medicare-enrolled provider, Robottom has provided services to 3,049 Medicare beneficiaries, totaling 77,742 services with total Medicare billing of $988,276. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Durham, NC
- Active Since 03/20/2007
- Last Updated 08/03/2011
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1558486688
Products in Payments
- Xadago (Drug) $783.41
- BOTOX (Biological) $329.80
- TROKENDI XR (Drug) $113.70
- AUBAGIO (Drug) $98.55
- UBRELVY (Drug) $96.49
- LEMTRADA (Drug) $84.29
- KESIMPTA (Drug) $82.93
- Zinbryta (Biological) $78.99
- Rebif (Biological) $64.41
- Xeomin (Biological) $55.87
- ACTIVA (Device) $49.67
- Aimovig (Biological) $49.23
- Radicava (Drug) $45.92
- AIMOVIG (Biological) $44.54
- BOTOX (Drug) $44.40
- VYVGART HYTRULO (Drug) $40.54
- VYEPTI (Biological) $31.31
- AMYVID (Drug) $30.02
- APTIOM (Drug) $26.03
- COPAXONE (Drug) $25.10
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Durham
Mark Skeen, M.d, M.D
Neurology — Payments: $770,195
Neurology $770,195
Dr. Kevin Kahn, Md, MD
Neurology — Payments: $662,344
Neurology $662,344
Dr. Alan Finkel, Md, MD
Neurology — Payments: $405,703
Neurology $405,703
Natalia Gonzalez, Md, MD
Neurology — Payments: $219,812
Neurology $219,812
Dr. Anne Calhoun, Md, MD
Neurology — Payments: $203,020
Neurology $203,020
Dr. Jeffrey Guptill, M.d, M.D
Neurology — Payments: $191,526
Neurology $191,526